20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Freenome, Inc. Common stock (FRNM) operates in the DIAGNOSTICS & RESEARCH industry and is headquartered in Brisbane, United States with about 375 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, FRNM reported $30M in revenue and ($219M) in net income.
Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer.
Interactive charts & full statements → Open the FRNM valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total Revenue | $30M | $3M |
| Gross Profit | $28M | $0M |
| Gross Margin % | 93.6% | 11.0% |
| Operating Income (EBIT) | ($223M) | ($292M) |
| Operating Margin % | -734.9% | -10130.9% |
| Net Income | ($219M) | ($274M) |
| Net Margin % | -721.3% | -9521.9% |
| EBITDA | — | — |
| Earnings Per Share (EPS) | $-2.07 | $-2.59 |
| Shares Outstanding (M) | 106M | 106M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Cash from Operations (CFO) | ($111M) | ($196M) |
| Capital Expenditures (CapEx) | $21M | $60M |
| Free Cash Flow (FCF) | ($132M) | ($257M) |
| FCF Margin % | -433.2% | -8909.7% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total Assets | $507M | $552M |
| Cash & Cash Equivalents | $79M | $67M |
| Total Liabilities | $1.8B | $1.6B |
| Total Debt (Short + Long-Term) | $102M | $0M |
| Total Shareholders' Equity | ($1.3B) | ($1.1B) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive FRNM viewer.
About TickerBase · Data methodology & sources · Privacy · Terms